par Salvagno, Michele ;Geraldini, Federico;Coppalini, Giacomo;Robba, Chiara ;Gouvêa Bogossian, Elisa ;Annoni, Filippo ;Vitali, Eva;Sterchele, Elda ;Balestra, Costantino ;Taccone, Fabio
Référence Brain sciences, 14, 2, page (117)
Publication Publié, 2024-02
Référence Brain sciences, 14, 2, page (117)
Publication Publié, 2024-02
Article révisé par les pairs
Résumé : | Traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) are critical neurological conditions that necessitate specialized care in the Intensive Care Unit (ICU). Managing cerebral perfusion pressure (CPP) and mean arterial pressure (MAP) is of primary importance in these patients. To maintain targeted MAP and CPP, vasopressors and/or inotropes are commonly used. However, their effects on cerebral oxygenation are not fully understood. The aim of this review is to provide an up-to date review regarding the current uses and pathophysiological issues related to the use of vasopressors and inotropes in TBI and SAH patients. According to our findings, despite achieving similar hemodynamic parameters and CPP, the effects of various vasopressors and inotropes on cerebral oxygenation, local CBF and metabolism are heterogeneous. Therefore, a more accurate understanding of the cerebral activity of these medications is crucial for optimizing patient management in the ICU setting. |